Edward Goldstein1, Hieu H Nguyen1, Patrick Liu2, Cecile Viboud3, Claudia A Steiner4,5, Colin J Worby6, Marc Lipsitch1,7. 1. Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 2. Yale School of Medicine, New Haven, Connecticut. 3. Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda. 4. Agency for HealthCare Research and Quality, Department of Health and Human Services, Rockville, Maryland. 5. Institute for Health Research, Kaiser Permanente Colorado, Denver. 6. Department of Ecology and Evolutionary Biology, Princeton University, New Jersey. 7. Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Abstract
Background: While circulation of respiratory syncytial virus (RSV) results in high rates of hospitalization, particularly among young children and elderly individuals, little is known about the role of different age groups in propagating annual RSV epidemics. Methods: We evaluate the roles played by individuals in different age groups during RSV epidemics in the United States between 2001 and 2012, using the previously defined relative risk (RR) statistic estimated from the hospitalization data from the Healthcare Cost and Utilization Project. Transmission modeling was used to examine the robustness of our inference method. Results: Children aged 3-4 years and 5-6 years each had the highest RR estimate for 5 of 11 seasons included in this study, with RSV hospitalization rates in infants being generally higher during seasons when children aged 5-6 years had the highest RR estimate. Children aged 2 years had the highest RR estimate during one season. RR estimates in infants and individuals aged ≥11 years were mostly lower than in children aged 1-10 years. Highest RR values aligned with groups for which vaccination had the largest impact on epidemic dynamics in most model simulations. Conclusions: Our estimates suggest the prominent relative roles of children aged ≤10 years (particularly among those aged 3-6 years) in propagating RSV epidemics. These results, combined with further modeling work, should help inform RSV vaccination policies.
Background: While circulation of respiratory syncytial virus (RSV) results in high rates of hospitalization, particularly among young children and elderly individuals, little is known about the role of different age groups in propagating annual RSV epidemics. Methods: We evaluate the roles played by individuals in different age groups during RSV epidemics in the United States between 2001 and 2012, using the previously defined relative risk (RR) statistic estimated from the hospitalization data from the Healthcare Cost and Utilization Project. Transmission modeling was used to examine the robustness of our inference method. Results:Children aged 3-4 years and 5-6 years each had the highest RR estimate for 5 of 11 seasons included in this study, with RSV hospitalization rates in infants being generally higher during seasons when children aged 5-6 years had the highest RR estimate. Children aged 2 years had the highest RR estimate during one season. RR estimates in infants and individuals aged ≥11 years were mostly lower than in children aged 1-10 years. Highest RR values aligned with groups for which vaccination had the largest impact on epidemic dynamics in most model simulations. Conclusions: Our estimates suggest the prominent relative roles of children aged ≤10 years (particularly among those aged 3-6 years) in propagating RSV epidemics. These results, combined with further modeling work, should help inform RSV vaccination policies.
Authors: Edward Goldstein; Sharon K Greene; Donald R Olson; William P Hanage; Marc Lipsitch Journal: Influenza Other Respir Viruses Date: 2015-09 Impact factor: 4.380
Authors: Timothy M Kinyanjui; Thomas A House; Moses C Kiti; Patricia A Cane; David J Nokes; Graham F Medley Journal: PLoS One Date: 2015-09-21 Impact factor: 3.240
Authors: Michiel van Boven; Anne C Teirlinck; Adam Meijer; Mariëtte Hooiveld; Christiaan H van Dorp; Rachel M Reeves; Harry Campbell; Wim van der Hoek Journal: J Infect Dis Date: 2020-10-07 Impact factor: 5.226
Authors: Kyra H Grantz; Derek A T Cummings; Shanta Zimmer; Charles Vukotich; David Galloway; Mary Lou Schweizer; Hasan Guclu; Jennifer Cousins; Carrie Lingle; Gabby M H Yearwood; Kan Li; Patti Calderone; Eva Noble; Hongjiang Gao; Jeanette Rainey; Amra Uzicanin; Jonathan M Read Journal: Sci Rep Date: 2021-01-27 Impact factor: 4.379
Authors: Carmen S Arriola; Lindsay Kim; Gayle Langley; Evan J Anderson; Kyle Openo; Andrew M Martin; Ruth Lynfield; Erica Bye; Kathy Como-Sabetti; Arthur Reingold; Shua Chai; Pam Daily; Ann Thomas; Courtney Crawford; C Reed; S Garg; Sandra S Chaves Journal: J Pediatric Infect Dis Soc Date: 2020-11-10 Impact factor: 3.164
Authors: P M De Salazar; D Gómez-Barroso; D Pampaka; J M Gil; B Peñalver; C Fernández-Escobar; M Lipsitch; A Larrauri; E Goldstein; M A Hernán Journal: Epidemiol Infect Date: 2020-10-21 Impact factor: 2.451